Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.

Forne et al1 concluded that the Das-1 monoclonal antibody was not as sensitive as we reported earlier as a premalignant marker for gastric intestinal metaplasia (GIM) associated with gastric cancer.2 The monoclonal antibody Das-1, developed by us, recognizes the colonic phenotype (type III or incomplete) of GIM, …